Pillar Pharmaceuticals II, L.P., 10% Owner at IDERA PHARMACEUTICALS, INC. (IDRA), sold 411,893 shares at $5.62 ($2.4M) on 2018-08-07, disclosed to the SEC on 2018-08-17.
Open-market sale of $2.4M IDRA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.55 | 91,893 | $510K | 21.5% |
| 2 | $5.55 | 91,893 | $510K | 21.5% |
| 3 | $5.62 | 75,000 | $422K | 17.8% |
| 4 | $5.88 | 50,000 | $294K | 12.4% |
| 5 | $5.89 | 8,107 | $48K | 2.0% |
| 6 | $5.98 | 20,000 |
| $120K |
| 5.0% |
| 7 | $5.98 | 20,000 | $120K | 5.0% |
| 8 | $6.25 | 15,000 | $94K | 4.0% |
| 9 | $6.29 | 25,000 | $157K | 6.6% |
| 10 | $6.35 | 15,000 | $95K | 4.0% |
| Total | $5.75 avg | 411,893 | $2.4M | 100% |
| Filing → |
| IDRA | SELL | 2017-05-03 | $2.0M | — | Filing → |